Calcium chloride
As of the edition of 20 October 2026, Calcium chloride is a small molecule: marketed, first approved in 1957 (CA).
Sources: FDA Orange Book and Purple Book, other approval registers, ClinicalTrials.gov, ChEMBL.
The drug
- Status
- Marketed; latest approval 2025
- Kind
- Small molecule
- Brand name
- Lactated Ringer's In Plastic Container
- First approved
- 31 December 1957 (CA)
- Approvals on record
- 189 in 3 regions
- Holder of the most recent approval
- Clinigen; 19 holders in all
- Registered trials
- 15, 0 stopped early
- Disease areas
- Heart and blood vessels; Pregnancy and women's health; Urinary and reproductive; Cancer; Bones, joints and muscles; Eye
US protection
No US approval on record.
With no US approval on record there are no listed US patents or exclusivities.
This is the US only.
Registered trials
| Phase | Trials | Completed | Active | Stopped early |
|---|---|---|---|---|
| Phase not stated | 1 | 1 | 0 | 0 |
| Phase 1 | 4 | 3 | 0 | 0 |
| Phase 2 | 4 | 3 | 1 | 0 |
| Phase 3 | 3 | 1 | 0 | 0 |
| Phase 4 | 3 | 2 | 1 | 0 |
| All trials | 15 |
Who has held its approvals
| Company | Role | Years |
|---|---|---|
| Baxter Healthcare | Applicant | 1957 to now |
| Alcon | Later holder | 1980 to now |
| Pfizer | Acquired holder and Later holder | 1981 to now |
| B. Braun Medical | Later holder | 1992 to now |
| Johnson & Johnson | Later holder | 1994 to now |
| Abbott | Applicant | 2000 to now |
| Clinigen | Applicant | 2025 to now |